ホジキンリンパ腫治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR2869)
◆英語タイトル:Global Hodgkin's Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2869
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、ホジキンリンパ腫治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、コルチコステロイド)、用途別市場規模(病院、学術・研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ホジキンリンパ腫治療の市場動向
・企業の競争状況、市場シェア
・ホジキンリンパ腫治療の種類別市場規模(アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、コルチコステロイド)
・ホジキンリンパ腫治療の用途別市場規模(病院、学術・研究所)
・ホジキンリンパ腫治療の北米市場規模2016-2027(アメリカ、カナダ)
・ホジキンリンパ腫治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ホジキンリンパ腫治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ホジキンリンパ腫治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・ホジキンリンパ腫治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bristol Myers Squibb、F. Hoffmann-La Roche、Merck、Pfizer)
・結論
【レポートの概要】

Hodgkin’s Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone. Generally surgery is not used as a treatment for the condition.
The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development process. High prevalence of cancer, increasing awareness regarding cancer treatment, technological advancements and high demand for safe and effective medication are driving the growth of the Hodgkin’s Lymphoma therapeutics pipeline.

Market Analysis and Insights: Global Hodgkin’s Lymphoma Therapeutics Market
The global Hodgkin’s Lymphoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hodgkin’s Lymphoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hodgkin’s Lymphoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hodgkin’s Lymphoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hodgkin’s Lymphoma Therapeutics market.

Global Hodgkin’s Lymphoma Therapeutics Scope and Market Size
Hodgkin’s Lymphoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hodgkin’s Lymphoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Alkylating Antineoplastic Agents
Antibiotic Antineoplastic Agents
Antineoplastics Vinca Alkaloid Agents
Podophyllotoxin Derivative Antineoplastic Agents
Antimetabolite Antineoplastic Agents
Anthracycline Antineoplastic Agents
Antimicrotubular Antineoplastics
Corticosteroids

Segment by Application
Hospitals
Academic and Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol Myers Squibb
F. Hoffmann-La Roche
Merck

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hodgkin’s Lymphoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Alkylating Antineoplastic Agents
1.2.3 Antibiotic Antineoplastic Agents
1.2.4 Antineoplastics Vinca Alkaloid Agents
1.2.5 Podophyllotoxin Derivative Antineoplastic Agents
1.2.6 Antimetabolite Antineoplastic Agents
1.2.7 Anthracycline Antineoplastic Agents
1.2.8 Antimicrotubular Antineoplastics
1.2.9 Corticosteroids
1.3 Market by Application
1.3.1 Global Hodgkin’s Lymphoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Academic and Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hodgkin’s Lymphoma Therapeutics Market Perspective (2016-2027)
2.2 Hodgkin’s Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Hodgkin’s Lymphoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hodgkin’s Lymphoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Hodgkin’s Lymphoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Hodgkin’s Lymphoma Therapeutics Industry Dynamic
2.3.1 Hodgkin’s Lymphoma Therapeutics Market Trends
2.3.2 Hodgkin’s Lymphoma Therapeutics Market Drivers
2.3.3 Hodgkin’s Lymphoma Therapeutics Market Challenges
2.3.4 Hodgkin’s Lymphoma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hodgkin’s Lymphoma Therapeutics Players by Revenue
3.1.1 Global Top Hodgkin’s Lymphoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Hodgkin’s Lymphoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Hodgkin’s Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hodgkin’s Lymphoma Therapeutics Revenue
3.4 Global Hodgkin’s Lymphoma Therapeutics Market Concentration Ratio
3.4.1 Global Hodgkin’s Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hodgkin’s Lymphoma Therapeutics Revenue in 2020
3.5 Hodgkin’s Lymphoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Hodgkin’s Lymphoma Therapeutics Product Solution and Service
3.7 Date of Enter into Hodgkin’s Lymphoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hodgkin’s Lymphoma Therapeutics Breakdown Data by Type
4.1 Global Hodgkin’s Lymphoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Hodgkin’s Lymphoma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Hodgkin’s Lymphoma Therapeutics Breakdown Data by Application
5.1 Global Hodgkin’s Lymphoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Hodgkin’s Lymphoma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hodgkin’s Lymphoma Therapeutics Market Size (2016-2027)
6.2 North America Hodgkin’s Lymphoma Therapeutics Market Size by Type
6.2.1 North America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Hodgkin’s Lymphoma Therapeutics Market Size by Application
6.3.1 North America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Hodgkin’s Lymphoma Therapeutics Market Size by Country
6.4.1 North America Hodgkin’s Lymphoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Hodgkin’s Lymphoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hodgkin’s Lymphoma Therapeutics Market Size (2016-2027)
7.2 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Type
7.2.1 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Application
7.3.1 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Country
7.4.1 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hodgkin’s Lymphoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hodgkin’s Lymphoma Therapeutics Market Size (2016-2027)
9.2 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Type
9.2.1 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Application
9.3.1 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Country
9.4.1 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Hodgkin’s Lymphoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hodgkin’s Lymphoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Hodgkin’s Lymphoma Therapeutics Introduction
11.1.4 Bristol Myers Squibb Revenue in Hodgkin’s Lymphoma Therapeutics Business (2016-2021)
11.1.5 Bristol Myers Squibb Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Hodgkin’s Lymphoma Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Hodgkin’s Lymphoma Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Hodgkin’s Lymphoma Therapeutics Introduction
11.3.4 Merck Revenue in Hodgkin’s Lymphoma Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hodgkin’s Lymphoma Therapeutics Introduction
11.4.4 Pfizer Revenue in Hodgkin’s Lymphoma Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ホジキンリンパ腫治療の世界市場規模・現状・予測2021年-2027年(Global Hodgkin's Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。